Egamid Limited 05077131 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is Consultancy services to the pharmaceutical sector. Digita Accounts Production Advanced 6.30.9574.0 true 05077131 2023-04-01 2024-03-31 05077131 2024-03-31 05077131 core:RetainedEarningsAccumulatedLosses 2024-03-31 05077131 core:ShareCapital 2024-03-31 05077131 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 05077131 bus:Micro-entities 2023-04-01 2024-03-31 05077131 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 05077131 bus:FilletedAccounts 2023-04-01 2024-03-31 05077131 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 05077131 bus:RegisteredOffice 2023-04-01 2024-03-31 05077131 bus:Director2 2023-04-01 2024-03-31 05077131 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 05077131 countries:EnglandWales 2023-04-01 2024-03-31 05077131 2022-04-01 2023-03-31 05077131 2023-03-31 05077131 core:RetainedEarningsAccumulatedLosses 2023-03-31 05077131 core:ShareCapital 2023-03-31 05077131 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 iso4217:GBP xbrli:pure

Registration number: 05077131

Egamid Limited



Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2024

 

Egamid Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3

 

Egamid Limited

Company Information

Director

Dr G Mennella

Registered office

Second Floor
150-151 Fleet Street
London
EC4A 2DQ

Registered number

05077131

Accountants

Gower Accountancy Limited
Chartered Certified Accountants
Second Floor
150-151 Fleet Street
London
EC4A 2DQ

 

Egamid Limited

(Registration number: 05077131)
Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

1

11,622

Current assets

 

586,227

676,950

Prepayments and accrued income

 

-

6,825

Creditors: Amounts falling due within one year

 

(22,853)

(50,506)

Net current assets

 

563,374

633,269

Total assets less current liabilities

 

563,375

644,891

Accruals and deferred income

 

(1,000)

(1,000)

Net assets

 

562,375

643,891

capital and reserves

 

Called up share capital

2

2

Profit and loss account

562,373

643,889

Capital and reserves

 

562,375

643,891

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Approved and authorised by the director on 8 November 2024
 

.........................................

Dr G Mennella

Director

 

Egamid Limited

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Second Floor
150-151 Fleet Street
London
EC4A 2DQ
United Kingdom

These financial statements were approved by the director on 8 November 2024.

Basis of preparation

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 2 (2023 - 2).